Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Prednisolone impurity 7 is a known impurity associated with the corticosteroid prednisolone. This compound is primarily utilized in quality control and analytical studies to assess the purity of prednisolone formulations. It serves as an important reference standard for researchers engaged in pharmaceutical research and development, ensuring compliance with regulatory guidelines and safety assessments. -
Drug Impurity
Buspirone impurity 3 is a known impurity of the anxiolytic agent buspirone. As a chemical research reagent, it plays a critical role in the analysis and characterization of drug purity and formulation. This compound is utilized in the development and quality control of pharmaceutical products to ensure compliance with regulatory standards. -
Drug Impurity
Apixaban impurity 6 is a noted impurity associated with the anticoagulant Apixaban. It serves as a reference standard for quality control and analytical purposes in pharmaceuticals. This compound is crucial for evaluating the purity of Apixaban formulations and ensuring compliance with regulatory standards in drug manufacturing and testing. -
Drug Impurity
Fluphenazine decanoate impurity 1 is identified as a drug impurity associated with Fluphenazine decanoate. This impurity serves as a critical marker for quality control and analytical studies in pharmaceutical development. It is crucial for researchers assessing the purity and stability of Fluphenazine formulations, contributing to the overall understanding of drug safety and efficacy. -
Drug Impurity
Meloxicam impurity 3 is a synthetic impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Meloxicam. It is primarily studied for its role in drug quality control and analytical chemistry applications. Understanding the characteristics and behavior of this impurity can aid in the development of safer and more effective pharmaceutical formulations, as well as in compliance with regulatory standards. -
Drug Impurity
Beclometasone dipropionate impurity 11 is a characterized impurity of the corticosteroid beclometasone dipropionate, primarily serving as a reference standard in analytical chemistry. It is utilized in the quality control and assessment of pharmaceutical formulations containing beclometasone dipropionate. This impurity aids in determining the purity and stability of drug products, contributing to regulatory compliance and ensuring product safety and efficacy. -
Drug Impurity
Rosuvastatin impurity 13 is a known impurity of the cholesterol-lowering agent Rosuvastatin, primarily utilized in drug quality control and analytical chemistry. It serves as an important reference standard for assessing the purity and stability of Rosuvastatin formulations. This compound is essential for ensuring compliance with regulatory standards during the development and manufacture of pharmaceutical products. -
Simethicone Impurity
Octamethyl-1,7-tetrasiloxanediol is a siloxane compound that serves as an impurity in Simethicone formulations. It is relevant in chemical research focused on identifying and characterizing impurities in silicone-based compounds. The compound's structural properties may also be investigated for their potential impact on the efficacy and safety profiles of silicone-derived products. -
Drug Impurity
Donepezil impurity 5, also known as Deoxydonepezil, is a recognized impurity associated with the pharmaceutical agent Donepezil. This compound serves as a critical reference standard for quality control and analytical studies in the development and validation of Donepezil formulations. Its characterization aids in ensuring the purity and safety of Donepezil-containing products in pharmaceutical research. -
Drug Impurity
Aceclofenac impurity 4, also known as Aceclofenac benzyl ester, is a recognized impurity associated with Aceclofenac. This compound is primarily utilized in the pharmaceutical industry for quality control and analytical purposes to assess the purity of Aceclofenac formulations. Its presence and characterization contribute to understanding the compound's stability and overall safety profile in drug development and manufacturing processes. -
Drug Impurity
Nimesulide impurity 1 is a known impurity of the analgesic and anti-inflammatory agent Nimesulide, primarily identified in quality control settings. This compound is essential for validating the purity of Nimesulide in pharmaceutical formulations and can be utilized in research focusing on drug metabolism and impurity profiling. Its presence can influence pharmacological studies and regulatory compliance assessments. -
Drug Impurity
Brimonidine impurity 2 is a known impurity associated with the drug Brimonidine, a selective alpha-2 adrenergic agonist. This compound is used in the research and development of pharmaceutical formulations to identify and quantify impurities in drug products. Analyzing this impurity is crucial for ensuring drug safety and efficacy, as well as for complying with regulatory standards in drug development. -
Drug Impurity
Citalopram impurity 3 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This compound serves as a reference standard for analytical testing and quality control in pharmaceutical development. Its identification is crucial for ensuring the purity and safety of Citalopram formulations in research and clinical applications. -
Drug Impurity
(Z)-3-propyl-2-(o-tolylimino)thiazolidin-4-one serves as a drug impurity with potential significance in pharmaceutical research. This compound may be important for the evaluation of drug stability, efficacy, and safety profiles during development. Its presence can influence the analytical methods employed in drug formulation and quality control studies, making it relevant for ensuring regulatory compliance and therapeutic integrity. -
Ambroxol hydrochloride Impurity
trans-4-(6,8-Dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride is an impurity of Ambroxol hydrochloride, functioning primarily as a chemical marker for quality control in pharmaceutical formulations. This compound can be useful in studies focusing on the metabolic pathways and degradation of Ambroxol, enabling researchers to assess the purity and stability of the main drug compound. Its characterization contributes to the understanding of related quinazoline derivatives in medicinal chemistry. -
Drug Impurity
Diclofenac impurity 4 sodium is a characterized impurity of Diclofenac sodium, primarily identified in pharmaceutical formulations. Its presence can influence drug efficacy and safety profiles, making it important for analytical research and quality control in drug development. This impurity serves as a reference standard in pharmacological studies and stability testing, aiding in the assessment of Diclofenac sodium purity and composition. -
Drug Impurity
Mesalazine impurity 9 is a known impurity associated with the anti-inflammatory drug mesalazine, primarily targeting the inhibition of leukotriene synthesis. This compound is significant for quality control in pharmaceutical research and development, particularly in assessing the purity of mesalazine formulations. Its characterization is essential for ensuring the safety and efficacy of mesalazine-based therapies. -
Drug Impurity
Flurbiprofen impurity 4 is a known impurity associated with Flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID). It serves as a critical reference standard for quality control in pharmaceutical development and regulatory compliance. This compound is essential for impurity profiling and evaluating the purity of Flurbiprofen formulations in research and development settings. -
Drug Impurity
Mycophenolate impurity 5 (Mycophenolic acid lactone) is an impurity associated with Mycophenolate. This compound is relevant for assessing the purity of Mycophenolate preparations in pharmaceutical research. Its characterization can aid in understanding the potential impact of impurities on drug efficacy and safety profiles in clinical applications. -
Drug Impurity
Irbesartan impurity 7 is a known impurity of the antihypertensive agent Irbesartan, primarily targeting the angiotensin II type 1 receptor. This reagent is essential for quality control and regulatory compliance in pharmaceutical development. Its analysis contributes to ensuring the safety and efficacy of Irbesartan formulations, making it a valuable tool in drug testing and characterization. -
Drug Impurity
Tamsulosin impurity 20 is a structural impurity related to the alpha-1 adrenergic antagonist Tamsulosin. This compound is primarily used for quality control in pharmaceutical research, particularly in the analysis of drug purity and characterization. Its presence in formulations can provide insights into synthesis processes and contribute to the optimization of drug manufacturing practices. -
Drug Impurity
Carvedilol impurity 3 is a drug impurity associated with Carvedilol, a non-selective beta-blocker. Its presence in formulations can impact the pharmacokinetics and safety profile of the drug, making it relevant for analytical and quality control applications in pharmaceutical research. This compound is utilized in the assessment of drug purity and regulatory compliance testing in the development of Carvedilol-based therapeutics. -
Drug Impurity
Clindamycin phosphate impurity 6, also known as Clindamycin 4-Phosphate, is a key impurity associated with Clindamycin phosphate. This compound is relevant in the field of pharmaceutical analysis and quality control, serving as a critical marker for assessing the purity of clindamycin formulations. Its identification is essential for ensuring compliance with regulatory standards and for studying the pharmacological properties and stability of clindamycin-based therapies. -
Drug Impurity
Levothyroxine impurity 9 is a chemical impurity associated with levothyroxine, a synthetic thyroid hormone. This compound is primarily used in research to study the effects of drug impurities on pharmacokinetics and pharmacodynamics. Its characterization and quantification are crucial for ensuring the quality and safety of levothyroxine formulations. As such, it serves as an essential tool in pharmaceutical development and quality control processes. -
Drug Impurity
Metronidazole impurity 2 (2-Methyl-5-nitro-1H-imidazole) is a recognized impurity found in Metronidazole. This compound is important for analytical studies of drug purity and stability, as well as for the development and optimization of pharmaceutical formulations. Its biological activity and role in metabolic pathways make it relevant for research in drug development and quality control processes. -
Drug Impurity
Chlorthalidone impurity 6 is a known impurity of the drug Chlorthalidone, a thiazide-like diuretic primarily targeting kidney function. Its presence can impact the efficacy and safety profile of pharmaceutical formulations. This reagent is essential for analytical research and quality control in drug development, facilitating the assessment of drug purity and compliance with regulatory standards. -
Drug Impurity
Fluphenazine decanoate impurity 5, also known as Fluphenazine octanoate, is a recognized impurity associated with Fluphenazine decanoate. Its primary relevance lies in pharmacological and toxicological studies, where it may be evaluated for effects on drug purity and stability. This compound is crucial for ensuring the safety and efficacy of formulations containing Fluphenazine decanoate in various therapeutic applications. -
Drug Impurity
Sildenafil impurity 7 is a known impurity of the phosphodiesterase type 5 (PDE5) inhibitor, Sildenafil. This compound is essential for quality control in pharmaceutical formulation, allowing for the assessment of purity and the identification of potential contaminants in Sildenafil production. Research applications include analytical method development and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Cinacalcet impurity 12 is a chemical impurity associated with the antihyperparathyroid agent cinacalcet, which primarily targets calcium-sensing receptors. This compound is utilized in analytical chemistry and quality control applications to ensure the purity and efficacy of cinacalcet formulations. Its characterization is essential for the development and validation of pharmacological assays, contributing to compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Pinaverium impurity 1 is a chemical impurity associated with Pinaverium, a known drug utilized in the treatment of gastrointestinal disorders. This impurity serves as a critical reference standard for quality control and analytical studies in pharmaceutical research. It aids in the assessment of drug purity and the identification of potential degradation products during formulation development. -
Drug Impurity
Mebendazole impurity 5 is a known impurity associated with the anthelmintic agent, Mebendazole. This compound serves as a critical reference standard in the quality control and characterization of pharmaceutical formulations. Its analysis is essential for assessing the purity of Mebendazole, ensuring compliance with regulatory standards in drug formulation and development. -
Drug Impurity
Tetrabenazine impurity 3 is a known impurity associated with Tetrabenazine, a medication used primarily for the treatment of hyperkinetic movement disorders. This compound is critical for analytical purposes in drug development, particularly in ensuring the purity and quality of pharmaceutical formulations. It serves as an important reference for researchers conducting stability studies and investigating the pharmacological effects of Tetrabenazine. -
Drug Impurity
Rivaroxaban impurity 17 is a chemical impurity associated with the anticoagulant drug Rivaroxaban. This compound is primarily studied in the context of drug quality assessment and formulation development. Its presence may affect the pharmacological profile and safety of Rivaroxaban, making it relevant for analytical research in pharmaceutical sciences. -
Drug Impurity
Everolimus impurity 4 is a chemical impurity associated with the immunosuppressant Everolimus. Its presence is significant for ensuring the analytical quality of pharmaceutical formulations and for conducting impurity profiling in drug development. This compound is utilized in quality control processes and stability studies to assess the purity and efficacy of Everolimus products. -
Drug Impurity
Rifampicin impurity 2, also known as Rifaldazinequinone, is a chemical byproduct associated with the production of Rifampicin. It is primarily investigated in the context of drug quality and safety to assess the stability and efficacy of Rifampicin formulations. Research applications include analytical studies focused on impurity profiling and the evaluation of the pharmacological effects of related compounds. -
Drug Impurity
Palbociclib impurity 48 is a chemical impurity associated with Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This impurity is essential for analytical and quality control studies in pharmaceutical development to ensure the purity of Palbociclib formulations. It is particularly relevant in the assessment of drug stability and safety profiles in cancer research applications. -
Drug Impurity
Duloxetine impurity 6, also known as Duloxetine N-desmethyl (R)-isomer, serves as an impurity associated with the pharmaceutical compound Duloxetine. This reagent is primarily utilized in drug development and analysis to assess purity levels and ensure compliance with regulatory standards. Its relevance is critical in studying the pharmacological properties and potential effects of the parent compound in various biological assays. -
Drug Impurity
Azilsartan impurity 23 is a chemical impurity associated with the antihypertensive drug Azilsartan, which targets the angiotensin II receptor. This compound is critical for validation studies and quality control in the pharmaceutical development of Azilsartan formulations. Its presence can influence drug efficacy and safety profiles, making it important for analytical research and regulatory compliance in the development of antihypertensive therapies. -
Drug Impurity
Quetiapine impurity 14 is a drug impurity associated with the antipsychotic agent Quetiapine. It serves as an important reference standard for the analysis and characterization of pharmaceutical formulations containing Quetiapine. This compound can be utilized in quality control processes to ensure the purity and compliance of therapeutic products in research and development settings. -
Drug Impurity
Trazodone impurity 8 hydrochloride is a chemical impurity associated with Trazodone hydrochloride. It serves as a reference standard for studies focused on the identification and quantification of impurities in pharmaceutical formulations. This compound is crucial for ensuring the safety and efficacy of Trazodone products in research applications involving pharmacokinetics and quality control assessments. -
Drug Impurity
Losartan impurity 20, also known as N2-Losartanyl-losartan, serves as a drug impurity related to the antihypertensive agent Losartan. This chemical compound is important for analytical purposes, particularly in the characterization and quantification of drug formulations. Its presence can impact the efficacy and safety profiles of Losartan-based therapies, making it relevant for quality control and stability studies in pharmaceutical research. -
Drug Impurity
Cinakase impurity 1 is a synthetic by-product associated with the production of Cinakase. This compound may impact drug formulation and quality control processes, making it essential for rigorous analytical investigations. Its profile is relevant for studies aiming to assess the stability and purity of pharmacological preparations containing Cinakase. -
Drug Impurity
Trazodone impurity 7 is a chemical impurity associated with trazodone, a serotonin antagonist and reuptake inhibitor. It may serve as a reference standard in analytical studies for the detection and quantification of trazodone impurities in pharmaceutical formulations. This compound is essential for researchers focused on drug purity, stability, and the assessment of trazodone's quality in compliance with regulatory standards. -
Drug Impurity
Tofacitinib impurity 59 is a chemical impurity associated with the JAK inhibitor Tofacitinib. This impurity is relevant for analytical and regulatory research purposes, particularly in the study of drug formulation and stability. It can be employed in quality control processes to ensure the purity and integrity of pharmaceutical products containing Tofacitinib. -
Drug Impurity
Lopinavir impurity 20, also known as Lopinavir impurity Q, is a chemical impurity associated with the antiretroviral drug Lopinavir. It is utilized primarily in drug formulation and quality control studies to ensure the purity and efficacy of pharmaceutical preparations. The characterization of this impurity is essential for compliance with regulatory standards and to support research on the pharmacological profile of Lopinavir. -
Drug Impurity
Nimesulide impurity 7, also known as 4-Nitro-2-phenoxyphenol, is a drug impurity associated with the non-steroidal anti-inflammatory drug Nimesulide. This compound is significant for analytical chemistry applications, particularly in the purity assessment and quality control of pharmaceutical formulations. Understanding this impurity's behavior and effects is essential for regulatory compliance and ensuring the safety and efficacy of Nimesulide-containing products. -
Drug Impurity
Carvedilol impurity 1 is a minor impurity associated with Carvedilol, a non-selective beta-blocker. This compound is utilized primarily in the pharmaceutical industry for quality control and stability testing of Carvedilol formulations. Its analysis is crucial for ensuring the purity and safety of the final drug product in compliance with regulatory standards. Researchers can leverage this impurity in studies focused on drug metabolism and pharmacokinetics. -
Drug Impurity
Estradiol benzoate impurity 1 is a chemical impurity associated with Estradiol benzoate, a synthetic derivative of estrogen. This compound serves as a critical reference for quality control and analytical testing in drug manufacturing processes. Its characterization is essential for ensuring the purity and safety of estradiol-based pharmaceuticals, contributing to compliance with regulatory standards in the pharmaceutical industry. -
Drug Impurity
Citalopram impurity 7 hydrochloride is a drug impurity associated with Citalopram hydrochloride. This compound is utilized in pharmaceutical research to assess the purity and stability of citalopram formulations and to investigate potential effects on drug efficacy and safety profiles. Its analysis is crucial for ensuring the quality of citalopram-based therapies in clinical applications. -
Drug Impurity
Azithromycin impurity 6, also known as Azithromycin C, is a characterized impurity associated with the antibiotic azithromycin. Its presence is significant in drug formulation and quality control contexts, serving as a reference standard for analytical evaluation. This reagent is essential for assessing the purity and stability of azithromycin, aiding in the development of pharmaceutical formulations and compliance with regulatory standards.
